-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901. Health Services Research—Non-Malignant Conditions: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Anemias, autoimmune disorders, Coronaviruses, Follicular Lymphoma, Hemophilia, Leukemia, multiple myeloma, SARS-CoV-2/COVID-19, sickle cell disease, survivorship, Bleeding and Clotting, CLL, CML, Diseases, Lymphoma (any), Marginal Zone Lymphoma, Non-Biological, smoldering myeloma, Bone Marrow Failure, CMML, Elderly, Hodgkin Lymphoma, LGLL, Mantle Cell Lymphoma, Therapies, Adverse Events, chemotherapy, CNS Lymphoma, Genetic Disorders, MDS, Non-Hodgkin Lymphoma, Pediatric, red blood cells, B-Cell Lymphoma, Biological Processes, DLBCL, Hemoglobinopathies, MPN, Thrombosis, Immune Disorders, T-Cell Lymphoma, Technology and Procedures, Cell Lineage, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, hematopoiesis, imaging, Quality Improvement , Thrombotic Disorders, VTE
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Amanda B. Blair, MD1, Kate Nammacher, MPH2*, Anne Jacobson, MS3*, Jeffrey D Carter, PhD3* and Tamar Sapir, PhD3*

1Seattle Children's Hospital, Seattle, WA
2National Hemophilia Foundation, New York, NY
3PRIME Education, LLC, Ft Lauderdale, FL

Hamda Khan, MA1*, Nariman Ammar, PhD2*, Jerlym S. Porter, PhD, MPH3, Juan Ding, PhD4*, Jeremie H. Estepp, MD1, Jason R. Hodges, PhD, MA1*, Arash Shaban-Nejad, PhD, MPH2*, Winfred Wang, MD1, James G Gurney, PhD5*, Guolian Kang, PhD4*, Robert Davis, MD, MPH6* and Jane S. Hankins, MD, MS7

1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
2UTHSC-ORNL Center for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, TN
3Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
5School of Public Health, University of Memphis, Memphis, TN
6Center for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, TN
7Associate Member, Director of the Sickle Cell Program, St. Jude Children's Research Hospital, Memphis, TN

Urshila Durani1, Ana I. Velazquez Manana, MD, MSc2,3, Jori May, MD4, Marquita Nelson, MD5, Ze Zheng, MBBS, PhD6, Anurekha Gollapudi, MD7, Sara Taveras Alam, MD8*, Robby Reynolds, MPA9, John Colton Thompson9*, Ashok Kumbamu, PhD10*, Devika G. Das, MD11*, Martina C. Murphy, MD12, Elizabeth Henry, MD13,14*, Alfred Ian Lee, MD, PhD15, Ariela L. Marshall, MD16,17, Ted Wun, MD18 and Lachelle Weeks, MD, PhD19

1Department of Hematology and HCT, City of Hope, Rochester, MN
2Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
3National Clinician Scholars Program, Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA
4Division of Hematology-Oncology, University of Alabama at Birmingham Medical Center, Birmingham, AL
5Division of Hematology and Oncology, University of Tennessee Health Science Center, Memphis, TN
6Division of Endocrinology, Medical College of Wisconsin, Milwaukee
7Department of Pediatrics, University of Washington, Seattle, WA
8Division of Hematology and Oncology, Baylor College of Medicine, Houston, TX
9American Society of Hematology, Washington, DC
10Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN
11Division of Hematology and Oncology, University of Alabama Medical Center, Birmingham, AL
12Division of Hematology and Oncology, University of Florida, Gainesville, FL
13Department of Medical Education, Loyola University Medical Center, Maywood, IL
14Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
15Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
16Division of Hematology, Mayo Clinic, Rochester, MN
17Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
18Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
19Harvard Medical School, Dana Farber Cancer Institute, Boston, MA

Shelby Meckstroth1*, Rong Wang, PhD2,3*, Xiaomei Ma, PhD4* and Nikolai A. Podoltsev, MD, PhD5,6

1Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT
2Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, New Haven, CT
3Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT
4School of Public Health, Yale University, New Haven, CT
5Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Madison, CT
6Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT

Eric Wittbrodt1*, Glen James2*, Supriya R. Kumar1*, Juan Jose Garcia Sanchez2*, Hungta Chen1*, James A. Sloand1* and Kamyar Kalantar-Zadeh3*

1AstraZeneca, Gaithersburg, MD
2AstraZeneca, Cambridge, United Kingdom
3University of California - Irvine, Irvine, CA

Shannon Phillips, PhD, RN1*, Alyssa M Schlenz, PhD2*, Mary Dooley, MS3*, Martina Mueller, PhD1*, Logan P Sirline, MPH3*, Cathy L Melvin, PhD, MPH4*, Robert J Adams, MD, MS5* and Julie Kanter, MD6

1College of Nursing, Medical University of South Carolina, Charleston, SC
2University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, CO
3Medical University of South Carolina, Charleston, SC
4Public Health Sciences, Medical University of South Carolina, Charleston, SC
5Neurology and Neurosurgery, Medical University of South Carolina, Charleston, SC
6Hematology/Oncology, Comprehensive Sickle Cell Center, University of Alabama at Birmingham, Birmingham, AL

Martin H. Ellis, MD1,2*, Tamar Tadmor, MD3,4*, Gabriel Chodick, PhD5,6*, Naama Yekutiel, MSc7*, Moti Levi8*, Giora Sharf8*, Oren Feine, PhD9*, Raanan Leef, BSc, MBA9*, Nana Ben Zvi, MD9* and Oren Shavit, PhD9*

1Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
2Hematology Institute, Meir Medical Center, Kfar Saba, Israel
3The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
4Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
5Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
6School of Public Health, Tel-Aviv University, Tel-Aviv, Israel
7Kahn-Sagol-Maccabi Research and Innovation Institute, Maccabi Healthcare Services, Tel-Aviv, Israel
8CML Advocates Network, Netanya, Israel
9Novartis Israel Ltd., a company wholly owned by Novartis Pharma AG., Tel-Aviv, Israel

Mansi R Shah, MD1, Imraan Jan, DO1*, Jeremy Johns, MD2*, Kuldip Singh, MD2*, Pallavi Kumar, MD2*, Norma Belarmino, MHSA1*, Kara Saggiomo, MSN1*, Carolyn Hayes, RN, PhD1*, Deborah Toppmeyer, MD1*, Kimyatta Washington, MHSA3*, Bruce Haffty, MD1*, Steven Libutti, MD1* and Andrew M. Evens, DO, MMSc1

1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
2Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
3Robert Wood Johnson University Hospital, RWJBarnabas Health, New Brunswick, NJ

Ednajoy Ngo1*, Cheng Ean Chee, MBBS, ABIM (Med Onc), ABIM (Heme), FCAP2*, Melinda Khoo, BSc (Hons)3*, Yee Mei Lee, BSN, MN, PhD1*, Belinda Tan, BHSN, GradDipNsg(Onc)1*, Yen-Lin Chee, MBChB, FRCPath, PhD2 and Wei-Ying Jen, MA, FRCPath, MD2

1Division of Oncology Nursing, National University Cancer Institute, Singapore, Singapore, Singapore
2Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore
3Operations and Administration, National University Cancer Institute, Singapore, Singapore, Singapore

Urania Dagalakis, MD1*, Henna Butt, MD1*, Natalie Davis, MD, MMSc1,2* and Regina A. Macatangay, MD1,3

1Department of Pediatrics, University of Maryland Children's Hospital, Baltimore, MD
2Division of Neonatology, University of Maryland, Baltimore, MD
3Division of Pediatric Hematology/Oncology, University of Maryland, Baltimore, MD

Sarah Sharman Moser, MSc1*, Galia Spectre, MD2*, Pia Raanani, MD2, Orr Friedman, PhD3*, Matanya Tirosh, PharmD3*, Gabriel Chodick, PhD1* and Avi Leader, MD2*

1Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
3Pfizer Pharmaceuticals Israel Ltd., Herzliya, Israel

Carmen Landry1*, Jon Dorling, MD2*, Ketan Kulkarni, MD3, Marsha Campbell-Yeo, PhD4*, Michael Vincer, MD4*, Joyce Ledwidge, PDt4*, Lisa Morrison, PDt4* and Satvinder Ghotra, MD5*

1Dalhousie University, Halifax, NS, Canada
2Pediatrics, Dalhousie University, Halifax, NS, Canada
3Division of Paediatric Hematology Oncology, Department of Paediatrics, IWK Health Centre, Halifax, NS, Canada
4Pediatrics, IWK Health Centre, Halifax, NS, Canada
5IWK Health Centre, Halifax, NS, Canada

Monika Oliver, MD, BSc1, Mariam Goubran, BSc1*, Jacqueline Karathra, BMSc1*, Mohammad Karkhaneh, PhD2* and Cynthia M. Wu, MD, FRCPC3

1University of Alberta, Edmonton, AB, Canada
2Institute of Health Economics, Edmonton, AB, Canada
3Department of Medicine, University of Alberta, Edmonton, AB, Canada

Jun Su1, Katherine Kosa2* and Dana DiBenedetti2*

1Sanofi, Cambridge, MA
2RTI Health Solutions, Research Triangle Park, NC

Ioannis Milioglou, MD1*, Sanjay P Ahuja, MD2 and Nathan Richard Stehouwer, MD3*

1University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH
2University Hospitals Cleveland Medical Center, Rainbow Babies and Children's Hospital, Cleveland, OH
3University Hospitals Rainbow Babies & Children’s Hospital, Cleveland, OH

Nina Anderson, DNP

TOVA Community Health in association with TOVA Healthcare, John Hopkins University, Thomas Jefferson University, University of Delaware, Delaware State University, Delaware, Department of Health and Social Services, Wilmington, DE

Srdan Verstovsek, MD, PhD1, Anne Jacobson, MS2*, Jeffrey D Carter, PhD2* and Tamar Sapir, PhD2*

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2PRIME Education, LLC, Ft Lauderdale, FL

Ruth Namazzi, MD1, Robert Opoka, MMED1*, Andrea L Conroy, PhD2*, Dibyadyuti Datta, PhD2*, Micheal Goings, MPH2* and Chandy C. John, MD, MS2*

1Pediatrics and Child Health, Makerere University, Kampala, Uganda
2Indiana University, Indianapolis, IN

Alberto Mussetti, MD1,2*, Clara Maluquer3*, Cristian Tebe Cordomi4*, Maria Condom, MD5*, Kevin Molina-Mata6*, Juan Antonio Marin Jimenez7*, Jose Carlos Tapia Tapia8*, Javier Gavira Diaz8*, Margarita Majem Tarruella8*, Felip Falgas9*, Laia Llobera Rius10*, Roser Fort Culillas11*, Lucia Llavata Martí12*, Miriam Moreno, MD13*, Susana Vives, MD13*, Rosa Coll, MD14*, Silvia Martin Batista15*, Carme Talarn16*, Miguel Sagüés17*, Ali Bazarbachi, MD, PhD18, Ramon Salazar19* and Anna Sureda Balari, MD, PhD20*

1Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, Spain
2Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain
3Hematology Department, Institut Catalá d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain
4Institute of Biomedical research of Bellvitge, IDIBELL, Hospitalet de Llobregat, Spain
5Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
6Medical Oncology, Institut Catalá d'Oncologia, Hematology Department, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain
7Medical Oncology, Institut Català d'Oncologia, Hematology Department, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain
8Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
9Medical Oncology, Hospital Germans Trias i Pujol, Institut Catalá d'Oncologia, Barcelona, Spain
10Medical Oncology Department, Hospital Germans Trias i Pujol, Institut Catalá d'Oncologia, Barcelona, Spain
11Hematology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Barcelona, Spain
12Medical Oncology Department, Hospital Germans Trias i Pujol, Institut Català d'Oncologia, Barcelona, Spain
13Medical Oncology Department, University Hospital Josep Trueta, Institut Català d'Oncologia, Girona, Spain
14Hematology Department, ICO - Hospital Doctor Josep Trueta, Girona, Spain
15Hematology Department, University Hospital Joan XXIII, Institut Català d'Oncologia, Tarragona, Spain
16Hematology Department, University Hospital Joan XXIII, Institut Català d'Oncologia, Tarragona, ESP
17Hematology Department, Hospital Duran i Reynals, Institut Catala d'Oncologia - L'Hospitalet de Llobregat, Barcelona, Spain
18Department of Hematology and bone marrow transplant, American University of Beyrouth, Beyrouth, Lebanon
19Medical Oncology, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain
20ICO-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain

Randall Curtis, MBA1*, Marilyn J Manco-Johnson, MD2, Barbara A. Konkle, MD3, Roshni Kulkarni, MD4, Joanne Wu, MD, MS5*, Judith Baker, DrPH, MHSA6*, Megan M. Ullman, MA, MPH7*, Duc Quang Tran Jr., MD8 and Michael B. Nichol, PhD9*

1Factor VIII Computing, Berkeley, CA
2University of Colorado Denver Hemophilia and Thrombosis Center, Aurora, CO
3University of Washington, Washington Center for Bleeding Disorders, Seattle, WA
4Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, MI
5University Of Southern California, Los Angeles, CA
6Center for Inherited Blood Disorders, Orange, CA
7Gulf States Hemophilia & Thrombophilia Center, University of Texas Health Science Center at Houston, Houston, TX
8Emory University, Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Atlanta, GA
9University of Southern California, Los Angeles, CA

Lindsay Wilde, MD1, Adam F. Binder, MD2, Matthew Carabasi, MD1*, Joanne Filicko-O'Hara, MD3*, John L. Wagner, MD1*, Onder Alpdogan, MD4*, Margaret Kasner, MD, MSc1, Thomas R. Klumpp, MD1, Ubaldo Martinez-Outschoorn, MD1*, Neil Palmisiano, MD, MS1, Gina Keiffer, MD1, Dolores Grosso, DNP, CRNP1, Michael Millenson5, Amy R. MacKenzie, MD6*, Allison Zibelli, MD7*, Neal Flomenberg, MD1, Pierluigi Porcu, MD1 and Usama Gergis, MD1

1Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
2Department of Medical Oncology, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, Philadelphia, PA
3Sidney Kimmel Cancer Center, Department of Medical Oncology, Division of Hematologic Malignancies and Stem Cell Transplant, Thomas Jefferson University Hospital, Philadelphia
4Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
5Sidney Kimmel Cancer Center, Department of Medical Oncology, Abington-Jefferson Health, Willow Grove, PA
6Thomas Jefferson University Hospital, Philadelphia, PA
7Jefferson University Hospital, Philadelphia, PA

Alice J. Cohen, MD

Division of Hematology/Oncology, Newark Beth Israel Med. Ctr., Newark, NJ; Newark Beth Israel Medical Center, Newark, NJ

Kwadwo Osei Bonsu, BPharm(Hons), PhD1*, Stephanie W Young, PharmD2,3*, Tiffany Lee, BSc(Pharm), Pharm.D1,3*, Hai V Nguyen, PhD1* and Rufaro S Chitsike, MBChB, MMed(Haem), FCPath(Haem), Cert Clin(Haem)4,5

1School of Pharmacy, Memorial University, St. John's, NF, Canada
2School of Pharmacy, Memorial University, St John's, NL, Canada
3Pharmacy Department, Eastern Health, St. John's, NF, Canada
4Division of Hematology, Eastern Health, St. John's, NF, Canada
5Division of Medicine (Hematology), Memorial University, St John's, NF, Canada

Derek Chan, MD, PhD1,2, Fiona Kouyoumdjian, MD, MPH, PhD, CCFP, FRCPC3*, Uma Athale, MD, MBBS, MSc4, Jacob Pendergrast, MD, FRCPC5,6 and Madeleine Verhovsek, MD, FRCPC7,8

1BC Children's Hospital, Vancouver, BC, Canada
2Department of Pediatrics, University of British Columbia, Faculty of Medicine, Vancouver, BC, Canada
3Department of Family Medicine, McMaster University, Hamilton, ON, Canada
4McMaster Children's Hospital, McMaster University, Division of Pediatric Hematology/Oncology, Hamilton, ON, Canada
5Laboratory Medicine Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada
6Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
7Division of Hematology and Thromboembolism, McMaster University, Hamilton, ON, Canada
8Medicine, St. Joseph's Hospital, Hamilton, ON, Canada

Hira Latif, MD1,2, Valentina Baez Sosa, MD2, Leslie Segal Kersun3*, Alison W. Loren, MD4, Hunter Groninger, MD2* and Aarthi Shenoy, MD2

1Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD
2MedStar Washington Hospital Center, Washington, DC
33401 Civic Center Blvd., Children's Hospital of Philadelphia, Philadelphia, PA
4Division of Hematology-Oncology/Department of Medicine, Perelman Center for Advanced Medicine, Philadelphia, PA

Caleb J Scheckel, DO1, Rajiv K. Pruthi, M.B.B.S1, Ariela L. Marshall, MD1, Aneel A. Ashrani, MD, MS1, Dong Chen, M.D., Ph.D.2 and Nahla M. Heikal, MD2*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Celine M. Vachon, PhD1, Josiah Murray2*, Cristine Allmer, BS3*, Dirk Larson, MS3*, Aaron D. Norman, MPH1*, Jason P Sinnwell, MS3*, Angela Dispenzieri, MD4, Geffen Kleinstern, PhD3, Robert A. Kyle, MD5, S. Vincent Rajkumar, MD5, Susan L. Slager, PhD3, Shaji K. Kumar, MD5 and David L. Murray, MD, PhD6*

1Division of Epidemiology, Mayo Clinic, Rochester, MN
2Medical College of Wisconsin, Milwaukee, WI
3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Mayo Clinic Rochester, Division of Hematology, Rochester, MN
6Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

*signifies non-member of ASH